Joslei Carlos BOHN, Lucimari TEİXEİRA, Cassiano Lima CHAİBEN, Adriano KUCZYNSKİ, Francisca Berenice Dias GİL, Antonio Adilson Soares De LİMA

Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report

Anahtar Kelimeler:

-

Management of Recurrent Herpes Labialis in Immunosuppressed Patient – A Case Report

Keywords:

-,

PDF

___

Neville B, Damm DD, Allen CM, Bouqout J, eds. Viral infections. In: Oral and Maxillofacial Pathology. 2nd ed. St. Louis: Saunders; 2002: 213-252.
Rooney JF, Straus SE, Mannix ML, Wohlenberg CR, Alling DW, Dumois JA, Notkins AL. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med. 1993; 118(4): 268-72.
Miller CS, Danaher RJ, Jacob RJ. Molecular Aspects of Herpes Simplex Virus I Latency, Reactivation, and Recurrence. Crit Rev Oral Biol Med. 1998 9: 541-562.
Habif TP. Herpes simplex. In: Baxter S, ed. Clinical dermatology: a color guide to diagnosis and therapy. 3rd ed. St. Louis. Mosby-Year Book, 1996: 325-44.
Corey L. Herpes simplex virus. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 5th ed. Philadelphia. Churchill Livingstone, 1998: 1564-80.
Brown RS, Eiland D. Palatal lesions in an otherwise healthy patient. J Am Dent Assoc. 2010; 141(4): 429-32.
He N, Chen L, Lin HJ, Zhang M, Wei J, Yang JH, Gabrio J, Rui BL, Zhang ZF, Fu ZH, Ding YY, Zhao GM, Jiang QW, Detels R. Multiple viral coinfections among HIV/AIDS patients in China. Biosci Trends. 2011; 5(1): 1-9.
Tugizov SM, Webster-Cyriaque JY, Syrianen S, Chattopadyay A, Sroussi H, Zhang L, Kaushal A. Mechanisms of viral infections associated with HIV: workshop 2B. Adv Dent Res. 2011; 23(1): 130-6.
Langley RG. Famciclovir for the treatment of recurrent genital and labial herpes lesions. Skin Therapy Lett. 2005; 10(10): 5-7.
Schubert MM. Oral manifestations of viral infections in immunocompromised patients. Curr Opin Dent. 1991; 1(4): 384- 97.
Whitley RJ, Roizman B: Herpes simplex virus infections. Lancet 2001; 357:1513–1518.
Ozcan A, Senol M, Saglam H, Seyhan M, Durmaz R, Aktas E, Ozerol IH: Comparison of the Tzanck test and polymerase chain reaction in the diagnosis of cutaneous herpes simplex and varicella zoster virus infections. Int J Dermatol 2007; 46:1177–1179.
Duggal MS, Abudiak H, Dunn C, Tong HJ, Munyombwe T. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS. Eur Arch Paediatr Dent. 2010; 11(5): 242-6.
Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008; 168(11): 1137-44.
U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Sexually transmitted diseases: treatment http://www.cdc.gov/std/treatment/2010/genital-ulcers.htm#hsv. Accessed June 2, 2011. 2010. Available at:
Straus SE, Croen KD, Sawyer MH, Freifeld AG, Felser JM, Dale JK, et al. Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment. JAMA. 1988; 260: 2227-30.
Kaplowitz LG, Baker D, Gelb L, Blythe J, Hale R, Frost P, et al. Prolonged continuous acyclovir treatment of normal adults with frequently recurring genital herpes simplex virus infection. JAMA. 1991; 265: 747-51.